Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Learn more about whether Legend Biotech Corporation or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Halozyme Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Shares of Incyte (INCY) fell 6% Monday after the company released its Q4 earnings report and 2025 sales forecast. Read more ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

Banca Popolare di Sondrio shares jumped Friday while BPER Banca shares slumped more than 8% on news of the bid. The sports-car maker warned that profits will be hurt this year as it spends more on ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.